137 related articles for article (PubMed ID: 27388654)
1. A possible pathogenetic role of IL-23/IL-17 axis in rheumatoid nodules in patients with rheumatoid arthritis.
Saito-Sasaki N; Sawada Y; Omoto D; Ohmori S; Haruyama S; Yoshioka M; Nishio D; Nakamura M
Clin Immunol; 2016 Sep; 170():20-1. PubMed ID: 27388654
[No Abstract] [Full Text] [Related]
2. Rheumatoid nodules indicating seronegative rheumatoid arthritis in a patient with gout.
Bachmeyer C; Charoud A; Mougeot-Martin M
Clin Rheumatol; 2003 May; 22(2):154-5. PubMed ID: 12740684
[TBL] [Abstract][Full Text] [Related]
3. Targeting IL-17 and Th17 cells in rheumatoid arthritis.
Sarkar S; Fox DA
Rheum Dis Clin North Am; 2010 May; 36(2):345-66. PubMed ID: 20510238
[TBL] [Abstract][Full Text] [Related]
4. Clinical pattern of rheumatoid arthritis in patients with rheumatoid nodules.
Maldyk H; Slotwińska L
Pol Med J; 1971; 10(1):24-30. PubMed ID: 4102356
[No Abstract] [Full Text] [Related]
5. Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation.
Robert M; Miossec P
Autoimmun Rev; 2024 Apr; 23(4):103529. PubMed ID: 38492906
[TBL] [Abstract][Full Text] [Related]
6. A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis.
Astry B; Harberts E; Moudgil KD
J Interferon Cytokine Res; 2011 Dec; 31(12):927-40. PubMed ID: 22149412
[TBL] [Abstract][Full Text] [Related]
7. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
[TBL] [Abstract][Full Text] [Related]
8. The contribution from interleukin-27 towards rheumatoid inflammation: insights from gene expression.
Millier MJ; Lazaro K; Stamp LK; Hessian PA
Genes Immun; 2020 Aug; 21(4):249-259. PubMed ID: 32518420
[TBL] [Abstract][Full Text] [Related]
9. Possible roles of IL-12-family cytokines in rheumatoid arthritis.
Pope RM; Shahrara S
Nat Rev Rheumatol; 2013 Apr; 9(4):252-6. PubMed ID: 23090510
[TBL] [Abstract][Full Text] [Related]
10. [Diffuse interstitial pulmonary fibrosis with positive rheumatoid serology and isolated subcutaneous rheumatoid nodules].
Ferme F; Chebat J; Menkes CJ
Nouv Presse Med; 1978 Sep; 7(29):2563. PubMed ID: 704316
[No Abstract] [Full Text] [Related]
11. Collagenolytic activity in rheumatoid nodules. I. Effect on acid-soluble tropocollagen.
Dabbous MK; Yamanishi Y; Maeyens E; Hashimoto K; Hardison H
Acta Derm Venereol; 1974; 54(4):265-9. PubMed ID: 4136598
[No Abstract] [Full Text] [Related]
12. Emerging role of IL-23 in rheumatoid arthritis.
Yuan FL; Li X; Sun JM; Xu RS
Clin Rheumatol; 2011 Aug; 30(8):1135-6. PubMed ID: 21681645
[No Abstract] [Full Text] [Related]
13. The IL-23-IL-17 axis in inflammatory arthritis.
Lubberts E
Nat Rev Rheumatol; 2015 Jul; 11(7):415-29. PubMed ID: 25907700
[TBL] [Abstract][Full Text] [Related]
14. Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies.
Bianchi E; Vecellio M; Rogge L
Front Immunol; 2021; 12():770275. PubMed ID: 34630440
[No Abstract] [Full Text] [Related]
15. Abnormal IgA levels in patients with rheumatoid arthritis.
Badcock LJ; Clarke S; Jones PW; Dawes PT; Mattey DL
Ann Rheum Dis; 2003 Jan; 62(1):83-4. PubMed ID: 12480680
[No Abstract] [Full Text] [Related]
16. Synovial fluid and serum levels of IL-17, IL-23, and CCL-20 in rheumatoid arthritis and psoriatic arthritis: a Tunisian cross-sectional study.
Mrabet D; Laadhar L; Sahli H; Zouari B; Haouet S; Makni S; Sellami S
Rheumatol Int; 2013 Jan; 33(1):265-6. PubMed ID: 22083617
[No Abstract] [Full Text] [Related]
17. Innate lymphocytes induce inflammatory bowel disease.
Diefenbach A; Vonarbourg C
Immunol Cell Biol; 2010 Oct; 88(7):694-6. PubMed ID: 20585336
[No Abstract] [Full Text] [Related]
18. Evolution of benign rheumatoid nodules into rheumatoid arthritis after 50 years.
Olivé A; Maymo J; Lloreta J; Corominas J; Carbonell J
Ann Rheum Dis; 1987 Aug; 46(8):624-5. PubMed ID: 3662651
[TBL] [Abstract][Full Text] [Related]
19. Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis.
Melis L; Vandooren B; Kruithof E; Jacques P; De Vos M; Mielants H; Verbruggen G; De Keyser F; Elewaut D
Ann Rheum Dis; 2010 Mar; 69(3):618-23. PubMed ID: 19196728
[TBL] [Abstract][Full Text] [Related]
20. The Rheumatoid nodule: peripheral or central to rheumatoid arthritis?
Highton J; Hessian PA; Stamp L
Rheumatology (Oxford); 2007 Sep; 46(9):1385-7. PubMed ID: 17623747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
